WithdrawnNot Applicable

Performance of Non-Invasive Monitors During ANH

Stopped: Study never commenced, and is now closed.

United States0Started 2022-11

Plain-language summary

The aim of this study is to assess the responsiveness of the standard minimally invasive hemodynamic monitors used in the operating room to known changes in the intravascular volume status that occur during blood removal and volume replacement with three different standard fluids used during ANH.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Those surgical procedures where ANH is included in the surgical plan and consent is obtained Exclusion Criteria: * Severe or symptomatic COPD, emphysema, renal, hepatic or coronary artery disease as defined by the American College of Cardiology (Cannon et al., 2001). * Esophageal pathology (diverticulum, hiatal hernia, esophageal cancer, esophageal surgery), which introduces risks associated with the placement of the esophageal Doppler. * Ascites. * BMI \>35 * Pregnancy

What they're measuring

Change in cardiac output

Timeframe: Baseline (Supine) Volume Replaced (S/P ANH)

Trial details

NCT IDNCT02179827

SponsorUniversity of California, Davis

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11

View on ClinicalTrials.gov More Baseline trials